View Future GrowthGPI 과거 순이익 실적과거 기준 점검 5/6GPI은 연평균 6.1%의 비율로 수입이 증가해 온 반면, Healthcare Services 산업은 수입이 1.6% 증가했습니다. 매출은 연평균 14.4%의 비율로 증가했습니다. GPI의 자기자본이익률은 5%이고 순이익률은 3%입니다.핵심 정보6.14%순이익 성장률-11.69%주당순이익(EPS) 성장률Healthcare Services 산업 성장률16.09%매출 성장률14.41%자기자본이익률5.03%순이익률2.96%다음 순이익 업데이트29 Sep 2026최근 과거 실적 업데이트Reported Earnings • Mar 31Full year 2025 earnings releasedFull year 2025 results: Revenue: €546.2m (up 7.1% from FY 2024). Net income: €16.2m (up 6.4% from FY 2024). Profit margin: 3.0% (in line with FY 2024). Revenue is forecast to grow 5.4% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Healthcare Services industry in Europe.공고 • Jan 22+ 1 more updateGPI S.p.A. to Report Fiscal Year 2025 Results on Mar 30, 2026GPI S.p.A. announced that they will report fiscal year 2025 results on Mar 30, 2026공고 • Jul 08GPI S.p.A. to Report First Half, 2025 Results on Sep 29, 2025GPI S.p.A. announced that they will report first half, 2025 results on Sep 29, 2025Reported Earnings • Mar 30Full year 2024 earnings releasedFull year 2024 results: Revenue: €509.9m (up 18% from FY 2023). Net income: €15.2m (up 485% from FY 2023). Profit margin: 3.0% (up from 0.6% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.2% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.Reported Earnings • Oct 02First half 2024 earnings releasedFirst half 2024 results: Revenue: €236.4m (up 23% from 1H 2023). Net income: €3.08m (up 439% from 1H 2023). Profit margin: 1.3% (up from 0.3% in 1H 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.분석 기사 • Apr 14GPI's (BIT:GPI) Problems Go Beyond Weak ProfitGPI S.p.A.'s ( BIT:GPI ) recent weak earnings report didn't cause a big stock movement. However, we believe that...모든 업데이트 보기Recent updatesUpcoming Dividend • Jul 13Upcoming dividend of €0.60 per shareEligible shareholders must have bought the stock before 20 July 2026. Payment date: 22 July 2026. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.1%. Lower than top quartile of Italian dividend payers (4.6%). Higher than average of industry peers (1.7%).Buy Or Sell Opportunity • Jul 09Now 22% overvaluedOver the last 90 days, the stock has fallen 11% to €14.78. The fair value is estimated to be €12.15, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 56%. For the next 3 years, revenue is forecast to grow by 4.6% per annum. Earnings are also forecast to grow by 22% per annum over the same time period.Buy Or Sell Opportunity • Jun 15Now 22% overvaluedOver the last 90 days, the stock has fallen 11% to €14.60. The fair value is estimated to be €11.95, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 56%. For the next 3 years, revenue is forecast to grow by 4.6% per annum. Earnings are also forecast to grow by 22% per annum over the same time period.Buy Or Sell Opportunity • May 27Now 21% overvaluedOver the last 90 days, the stock has fallen 16% to €14.78. The fair value is estimated to be €12.23, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 56%. For the next 3 years, revenue is forecast to grow by 4.6% per annum. Earnings are also forecast to grow by 22% per annum over the same time period.새로운 내러티브 • Apr 28Ehealth Tenders And AI Adoption Will Shape Margins While Valuation Remains BalancedCatalysts About GPI GPI provides eHealth and automation solutions for healthcare systems, with a focus on software for hospitals, diagnostics, critical care and drug management. What are the underlying business or industry changes driving this perspective?새로운 내러티브 • Apr 14Digital Health Transformation And AI Adoption Will Reshape This eHealth Provider’s Long Term ProspectsCatalysts About GPI GPI provides eHealth and digital health software, automation and related services to public and private health care customers in Italy and internationally. What are the underlying business or industry changes driving this perspective?Declared Dividend • Apr 01Dividend increased to €0.60Dividend of €0.60 is 20% higher than last year. Ex-date: 20th July 2026 Payment date: 22nd July 2026 Dividend yield will be 3.6%, which is higher than the industry average of 0.9%. Sustainability & Growth Dividend is not adequately covered by earnings (91% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 5.8% per year over the past 9 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 1.3% to bring the payout ratio under control. However, EPS is expected to remain steady over the next 2 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.Reported Earnings • Mar 31Full year 2025 earnings releasedFull year 2025 results: Revenue: €546.2m (up 7.1% from FY 2024). Net income: €16.2m (up 6.4% from FY 2024). Profit margin: 3.0% (in line with FY 2024). Revenue is forecast to grow 5.4% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Healthcare Services industry in Europe.공고 • Mar 31GPI S.p.A. announces Annual dividend, payable on July 22, 2026GPI S.p.A. announced Annual dividend of EUR 0.6000 per share payable on July 22, 2026, ex-date on July 20, 2026 and record date on July 21, 2026.분석 기사 • Jan 24Why Investors Shouldn't Be Surprised By GPI S.p.A.'s (BIT:GPI) P/EGPI S.p.A.'s ( BIT:GPI ) price-to-earnings (or "P/E") ratio of 31.3x might make it look like a strong sell right now...공고 • Jan 22+ 1 more updateGPI S.p.A. to Report Fiscal Year 2025 Results on Mar 30, 2026GPI S.p.A. announced that they will report fiscal year 2025 results on Mar 30, 2026Valuation Update With 7 Day Price Move • Nov 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €14.82, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Healthcare Services industry in Europe. Total returns to shareholders of 28% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.86 per share.New Risk • Nov 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Dividend is not well covered by earnings and cash flows. Payout ratio: 91% Dividend per share is over 21x cash flows per share. Minor Risk Share price has been volatile over the past 3 months (5.9% average weekly change).Price Target Changed • Oct 14Price target increased by 11% to €18.57Up from €16.67, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of €17.84. Stock is up 44% over the past year. The company is forecast to post earnings per share of €0.77 for next year compared to €0.53 last year.New Risk • Aug 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Dividend is not well covered by earnings and cash flows. Payout ratio: 95% Paying a dividend despite having no free cash flows. Minor Risk Share price has been volatile over the past 3 months (5.3% average weekly change).공고 • Jul 17KKR Reportedly Mulls Acquisition of GPIKKR & Co. Inc. (NYSE:KKR), the buyout firm that’s been scouting for takeover targets amid the recent market volatility, is considering a potential acquisition of Italian health-care technology firm GPI S.p.A. (BIT:GPI), according to people with knowledge of the matter. The US private equity firm has been speaking with advisers in recent weeks as it considers a potential deal to take Trent-based GPI private, the people said, asking not to be identified as the matter is private. The stock is up about 27% in Milan trading this year, giving the company a market value of about €385 million ($446 million). An investment vehicle backed by GPI Chief Executive Officer Fausto Manzana is the company’s biggest shareholder, with a 48% stake that’s equivalent to 57% of the voting rights, according to its annual report. Deliberations are ongoing, though there’s no certainty they will lead to a transaction, the people said. A representative for KKR declined to comment. A spokesperson for GPI didn’t comment.Upcoming Dividend • Jul 14Upcoming dividend of €0.50 per shareEligible shareholders must have bought the stock before 21 July 2025. Payment date: 23 July 2025. Payout ratio is on the higher end at 95% but the company is not cash flow positive. Trailing yield: 3.8%. Lower than top quartile of Italian dividend payers (5.1%). Higher than average of industry peers (1.1%).분석 기사 • Jul 10GPI S.p.A. (BIT:GPI) Stock Catapults 25% Though Its Price And Business Still Lag The IndustryDespite an already strong run, GPI S.p.A. ( BIT:GPI ) shares have been powering on, with a gain of 25% in the last...공고 • Jul 08GPI S.p.A. to Report First Half, 2025 Results on Sep 29, 2025GPI S.p.A. announced that they will report first half, 2025 results on Sep 29, 2025분석 기사 • Jul 05Why GPI S.p.A. (BIT:GPI) Could Be Worth WatchingGPI S.p.A. ( BIT:GPI ), might not be a large cap stock, but it saw a significant share price rise of 59% in the past...공고 • Jul 02GPI S.p.A. (BIT:GPI) acquired remaining 35% stake in Tesi Elettronica E Sistemi Informativi S.P.A. for €27.8 million.GPI S.p.A. (BIT:GPI) acquired remaining 35% stake in Tesi Elettronica E Sistemi Informativi S.P.A. for €27.8 million on June 30, 2025. The price for acquiring the remaining shares, which represent 35% of TESI's share capital, is €27.8 million i.e, Payment for the acquisition of a 35% stake in TESI was made using the following methods: (i) a €5 million deposit upon signing, of which €4 million in cash and €1 million via the transfer of Gpi; (ii) the amount of €15.9 million in cash paid at the closing, which took place today, 30 June 2025; (iii) the difference settled through the assumption and offsetting of the sellers’ payables to companies within the Tesi group. GPI S.p.A. (BIT:GPI) completed the acquisition of remaining 35% stake in Tesi Elettronica E Sistemi Informativi S.P.A. on June 30, 2025.Major Estimate Revision • Apr 16Consensus EPS estimates fall by 20%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from €0.98 to €0.783 per share. Revenue forecast steady at €534.8m. Net income forecast to grow 49% next year vs 42% growth forecast for Healthcare Services industry in Italy. Consensus price target of €16.67 unchanged from last update. Share price rose 7.7% to €8.66 over the past week.Major Estimate Revision • Apr 04Consensus EPS estimates increase by 31%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from €0.748 to €0.98. Revenue forecast steady at €530.9m. Net income forecast to grow 82% next year vs 36% growth forecast for Healthcare Services industry in Italy. Consensus price target of €16.67 unchanged from last update. Share price fell 8.8% to €8.30 over the past week.공고 • Apr 02GPI S.p.A. announces Annual dividend, payable on July 23, 2025GPI S.p.A. announced Annual dividend of EUR 0.5000 per share payable on July 23, 2025, ex-date on July 21, 2025 and record date on July 22, 2025.Reported Earnings • Mar 30Full year 2024 earnings releasedFull year 2024 results: Revenue: €509.9m (up 18% from FY 2023). Net income: €15.2m (up 485% from FY 2023). Profit margin: 3.0% (up from 0.6% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.2% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.공고 • Mar 20GPI S.p.A., Annual General Meeting, Apr 29, 2025GPI S.p.A., Annual General Meeting, Apr 29, 2025, at 11:00 W. Europe Standard Time.Buy Or Sell Opportunity • Jan 14Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 18% to €10.16. The fair value is estimated to be €12.76, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has declined by 54%. Revenue is forecast to grow by 12% in 2 years. Earnings are forecast to grow by 143% in the next 2 years.Buy Or Sell Opportunity • Dec 27Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 20% to €10.08. The fair value is estimated to be €12.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has declined by 54%. Revenue is forecast to grow by 12% in 2 years. Earnings are forecast to grow by 143% in the next 2 years.Upcoming Dividend • Dec 02Upcoming dividend of €0.35 per shareEligible shareholders must have bought the stock before 09 December 2024. Payment date: 11 December 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.5%. Lower than top quartile of Italian dividend payers (5.6%). Higher than average of industry peers (2.6%).Buy Or Sell Opportunity • Oct 03Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 1.8% to €12.74. The fair value is estimated to be €10.60, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 10% in 2 years. Earnings are forecast to grow by 187% in the next 2 years.Reported Earnings • Oct 02First half 2024 earnings releasedFirst half 2024 results: Revenue: €236.4m (up 23% from 1H 2023). Net income: €3.08m (up 439% from 1H 2023). Profit margin: 1.3% (up from 0.3% in 1H 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.Buy Or Sell Opportunity • Sep 09Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 1.2% to €12.28. The fair value is estimated to be €9.94, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has declined by 46%. For the next 3 years, revenue is forecast to grow by 7.3% per annum. Earnings are also forecast to grow by 47% per annum over the same time period.Buy Or Sell Opportunity • Aug 08Now 20% overvaluedOver the last 90 days, the stock has fallen 5.8% to €11.98. The fair value is estimated to be €9.94, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has declined by 46%. For the next 3 years, revenue is forecast to grow by 7.3% per annum. Earnings are also forecast to grow by 47% per annum over the same time period.Upcoming Dividend • May 20Upcoming dividend of €0.50 per shareEligible shareholders must have bought the stock before 27 May 2024. Payment date: 29 May 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 3.8%. Lower than top quartile of Italian dividend payers (5.3%). Higher than average of industry peers (1.6%).Price Target Changed • Apr 17Price target increased by 7.2% to €16.30Up from €15.20, the current price target is an average from 3 analysts. New target price is 30% above last closing price of €12.50. Stock is up 0.2% over the past year. The company is forecast to post earnings per share of €0.58 for next year compared to €0.09 last year.분석 기사 • Apr 14GPI's (BIT:GPI) Problems Go Beyond Weak ProfitGPI S.p.A.'s ( BIT:GPI ) recent weak earnings report didn't cause a big stock movement. However, we believe that...Major Estimate Revision • Apr 04Consensus EPS estimates fall by 41%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from €483.8m to €500.8m. EPS estimate fell from €0.973 to €0.57 per share. Net income forecast to grow 516% next year vs 47% growth forecast for Healthcare Services industry in Italy. Consensus price target up from €15.20 to €15.53. Share price was steady at €11.92 over the past week.Reported Earnings • Mar 31Full year 2023 earnings releasedFull year 2023 results: Revenue: €433.4m (up 20% from FY 2022). Net income: €2.60m (down 74% from FY 2022). Profit margin: 0.6% (down from 2.8% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.1% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.공고 • Mar 21Zucchetti Hospitality S.R.L. completed the acquisition of Argentea S.r.l. from GPI S.p.A. (BIT:GPI).Zucchetti Hospitality S.R.L. signed an agreement to acquire Argentea S.r.l. from GPI S.p.A. (BIT:GPI) for approximately €105 million on March 15, 2024. The consideration for the sale of 100% of Argentea S.r.l., to be paid in full in cash at closing, has been agreed upon at approximately €99 million, based on an equity value of Argentea S.r.l. of approximately €105 million. An earn-out clause is also provided for, whereby the buyer undertakes to pay Gpi S.p.A. an additional amount of €6 million, on the sole condition that Argentea S.r.l.'s FY 2024 EBITDA, to be calculated in continuity with previous management criteria, is at least equal to that of FY 2023. In FY 2023, Argentea S.r.l. reported production value of €16.3 million and EBITDA of €6.9 million. This transaction is expected to be completed by end of March 2024. Intermonte acted as financial advisor to Zucchetti Hospitality S.R.L. Equita acted as financial advisor, EY-Parthenon as industrial advisor and Studio Legale Pavia e Ansaldo acted as legal advisor to GPI S.p.A. (BIT:GPI). Zucchetti Hospitality S.R.L. completed the acquisition of Argentea S.r.l. from GPI S.p.A. (BIT:GPI) on March 20, 2024.분석 기사 • Feb 27Why Investors Shouldn't Be Surprised By GPI S.p.A.'s (BIT:GPI) 26% Share Price SurgeGPI S.p.A. ( BIT:GPI ) shares have continued their recent momentum with a 26% gain in the last month alone. Not all...Valuation Update With 7 Day Price Move • Feb 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €10.86, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Healthcare Services industry in Europe. Total returns to shareholders of 30% over the past three years.Valuation Update With 7 Day Price Move • Feb 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €10.86, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Healthcare Services industry in Europe. Total returns to shareholders of 30% over the past three years.분석 기사 • Dec 30GPI S.p.A.'s (BIT:GPI) P/E Is Still On The Mark Following 25% Share Price BounceGPI S.p.A. ( BIT:GPI ) shareholders would be excited to see that the share price has had a great month, posting a 25...분석 기사 • Dec 15These 4 Measures Indicate That GPI (BIT:GPI) Is Using Debt ExtensivelyDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...분석 기사 • Oct 27GPI (BIT:GPI) Is Reinvesting At Lower Rates Of ReturnWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...Price Target Changed • Oct 20Price target decreased by 9.3% to €15.20Down from €16.77, the current price target is an average from 3 analysts. New target price is 87% above last closing price of €8.14. Stock is down 31% over the past year. The company is forecast to post earnings per share of €0.78 for next year compared to €0.35 last year.Major Estimate Revision • Oct 01Consensus EPS estimates increase by 25%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has improved. 2023 revenue forecast increased from €418.4m to €426.1m. EPS estimate increased from €0.635 to €0.791 per share. Net income forecast to grow 81% next year vs 28% growth forecast for Healthcare Services industry in Italy. Consensus price target of €16.83 unchanged from last update. Share price fell 3.6% to €8.95 over the past week.Upcoming Dividend • May 08Upcoming dividend of €0.50 per share at 4.2% yieldEligible shareholders must have bought the stock before 15 May 2023. Payment date: 17 May 2023. Payout ratio is on the higher end at 85% but the company is not cash flow positive. Trailing yield: 4.2%. Lower than top quartile of Italian dividend payers (5.2%). Higher than average of industry peers (1.3%).Major Estimate Revision • Apr 18Consensus EPS estimates fall by 15%The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from €0.59 to €0.50. Revenue forecast unchanged from €420.5m at last update. Net income forecast to grow 47% next year vs 30% growth forecast for Healthcare Services industry in Italy. Consensus price target of €17.43 unchanged from last update. Share price fell 2.3% to €12.50 over the past week.Major Estimate Revision • Mar 31Consensus EPS estimates fall by 40%, revenue upgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from €409.2m to €420.5m. EPS estimate fell from €0.981 to €0.59 per share. Net income forecast to grow 36% next year vs 30% growth forecast for Healthcare Services industry in Italy. Consensus price target broadly unchanged at €17.43. Share price fell 2.7% to €12.80 over the past week.Major Estimate Revision • Feb 19Consensus EPS estimates fall by 16%The consensus outlook for fiscal year 2022 has been updated. 2022 EPS estimate fell from €0.668 to €0.558 per share. Revenue forecast steady at €355.7m. Net income forecast to grow 37% next year vs 29% growth forecast for Healthcare Services industry in Italy. Consensus price target down from €18.03 to €17.63. Share price fell 3.8% to €13.76 over the past week.Major Estimate Revision • Dec 26Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from €0.85 to €0.65 per share. Revenue forecast steady at €354.8m. Net income forecast to grow 46% next year vs 39% growth forecast for Healthcare Services industry in Italy. Consensus price target broadly unchanged at €18.03. Share price was steady at €13.64 over the past week.Major Estimate Revision • Dec 08Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from €1.01 to €0.85 per share. Revenue forecast steady at €354.0m. Net income forecast to grow 47% next year vs 39% growth forecast for Healthcare Services industry in Italy. Consensus price target of €17.97 unchanged from last update. Share price was steady at €13.36 over the past week.공고 • Nov 23GPI S.p.A. acquired 65% stake in Tesi Elettronica E Sistemi Informativi S.P.A. from Tesi Group, Sorean S.r.l., Aef Luxor Group SL and Magica S.R.L. for Tesi Elettronica E Sistemi Informativi S.P.A. for €58.5 million.GPI (GPI:IM) signed the letter of intent to acquire 75% stake in Tesi Elettronica E Sistemi Informativi S.P.A. from Tesi Group, Sorean S.r.l., Aef Luxor Group SL and Magica S.R.L. on January 4, 2022. On May 23, 2022, GPI S.p.A. signed an agreement to acquire a 65% stake in Tesi Elettronica E Sistemi Informativi S.P.A. from Tesi Group, Sorean S.r.l., Aef Luxor Group SL and Magica S.R.L. for Tesi Elettronica E Sistemi Informativi S.P.A. for €58.5 million. The consideration will be settled in the following ways: a deposit of €8 million at signing; €28.3 million to be paid at the closing, the remaining portion, equal to €22.2 million, by January 31, 2023. Completion of the transaction is subject to the approval of the competent bodies, as well as to any authorizations necessary from the antitrust authorities. The transaction is expected to complete by September 30, 2022. On May 23, 2022, GPI S.p.A. agreed with the selling parties to extend the closing date to November, 29 2022. GPI S.p.A. completed the acquisition of 65% stake in Tesi Elettronica E Sistemi Informativi S.P.A. from Tesi Group, Sorean S.r.l., Aef Luxor Group SL and Magica S.R.L. for Tesi Elettronica E Sistemi Informativi S.P.A. for €58.5 million on November 21, 2022. The consideration of €28.3 million paid at the closing was funded using a combination of available liquidity and short-term bank loans. Studio Baldi & Partners acted as legal advisor, Intermonte SIM S.p.A. acted as financial advisor to GPI S.p.A.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Independent Director Michele Andreaus was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.분석 기사 • Nov 02Is There Now An Opportunity In GPI S.p.A. (BIT:GPI)?GPI S.p.A. ( BIT:GPI ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the...Reported Earnings • Sep 18First half 2022 earnings releasedFirst half 2022 results: Revenue: €168.9m (up 11% from 1H 2021). Net income: €331.0k (up €359.0k from 1H 2021). Profit margin: 0.2% (up from 0% in 1H 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10.0% growth forecast for the Healthcare Services industry in Europe.Price Target Changed • Aug 17Price target decreased to €16.10Down from €18.50, the current price target is an average from 2 analysts. New target price is 15% above last closing price of €14.02. Stock is up 12% over the past year. The company is forecast to post earnings per share of €0.90 for next year compared to €0.61 last year.분석 기사 • Jun 18What Does GPI S.p.A.'s (BIT:GPI) Share Price Indicate?GPI S.p.A. ( BIT:GPI ), might not be a large cap stock, but it saw significant share price movement during recent...Upcoming Dividend • May 09Upcoming dividend of €0.50 per shareEligible shareholders must have bought the stock before 16 May 2022. Payment date: 18 May 2022. Payout ratio is on the higher end at 82% but the company is not cash flow positive. Trailing yield: 3.8%. Lower than top quartile of Italian dividend payers (4.8%). Higher than average of industry peers (1.4%).Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 7 experienced directors. 4 highly experienced directors. 4 independent directors (6 non-independent directors). Independent Director Michele Andreaus was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Buying Opportunity • Mar 31Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be €17.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 14%. Revenue is forecast to grow by 14% in 2 years. Earnings is forecast to grow by 42% in the next 2 years.Price Target Changed • Jan 06Price target increased to €18.50Up from €17.07, the current price target is an average from 3 analysts. New target price is 10% above last closing price of €16.75. Stock is up 113% over the past year. The company is forecast to post earnings per share of €0.79 for next year compared to €0.75 last year.공고 • Jan 06GPI (GPI:IM) signed the letter of intent to acquire 75% stake in Tesi Elettronica E Sistemi Informativi S.P.A. from Tesi Group, Sorean S.r.l., Aef Luxor Group SL and Magica S.R.L.GPI (GPI:IM) signed the letter of intent to acquire 75% stake in Tesi Elettronica E Sistemi Informativi S.P.A. from Tesi Group, Sorean S.r.l., Aef Luxor Group SL and Magica S.R.L. on January 4, 2022.The letter of intent, guaranteed by an exclusivity clause until 28 February 2022, provides for the signing of the binding agreement by 28 February 2022 and for the closing, indicatively by 30 April 2022, subject to the positive and satisfactory outcome of the due diligence carried out by GPI. Completion of the transaction is subject to the approval of the competent bodies, as well as to any authorizations necessary from the antitrust authorities.분석 기사 • Dec 27Here's What To Make Of GPI's (BIT:GPI) Decelerating Rates Of ReturnFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...분석 기사 • Nov 30Here's Why GPI (BIT:GPI) Has A Meaningful Debt BurdenSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Price Target Changed • Nov 27Price target increased to €18.17Up from €16.73, the current price target is an average from 3 analysts. New target price is 42% above last closing price of €12.80. Stock is up 79% over the past year. The company is forecast to post earnings per share of €0.83 for next year compared to €0.75 last year.분석 기사 • Oct 06GPI's (BIT:GPI) Promising Earnings May Rest On Soft FoundationsDespite posting some strong earnings, the market for GPI S.p.A.'s ( BIT:GPI ) stock hasn't moved much. Our analysis...Price Target Changed • Jul 27Price target increased to €16.23Up from €14.63, the current price target is an average from 3 analysts. New target price is 21% above last closing price of €13.45. Stock is up 94% over the past year.Upcoming Dividend • Jul 19Upcoming dividend of €0.50 per shareEligible shareholders must have bought the stock before 26 July 2021. Payment date: 28 July 2021. Trailing yield: 3.6%. Lower than top quartile of Italian dividend payers (3.8%). Higher than average of industry peers (1.0%).분석 기사 • Jun 05An Intrinsic Calculation For GPI SpA (BIT:GPI) Suggests It's 33% UndervaluedToday we'll do a simple run through of a valuation method used to estimate the attractiveness of GPI SpA ( BIT:GPI ) as...분석 기사 • Apr 30GPI (BIT:GPI) Has A Somewhat Strained Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Apr 13Is GPI SpA's (BIT:GPI) 5.0% Dividend Sustainable?Could GPI SpA ( BIT:GPI ) be an attractive dividend share to own for the long haul? Investors are often drawn to strong...분석 기사 • Mar 29GPI (BIT:GPI) Might Be Having Difficulty Using Its Capital EffectivelyFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...분석 기사 • Mar 07Is GPI SpA's (BIT:GPI) 12% ROE Strong Compared To Its Industry?One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...Major Estimate Revision • Feb 12Analysts increase EPS estimates to €0.64The 2020 consensus revenue estimate increased from €256.6m to €264.4m. The earnings per share estimate also received an upgrade from €0.52 to €0.64 for the same period. Net income is expected to shrink by 2.7% next year compared to 29% growth forecast for the Healthcare Services industry in Italy . The consensus price target increased from €10.50 to €10.85. Share price is up 8.1% to €9.08 over the past week.분석 기사 • Feb 08Estimating The Intrinsic Value Of GPI SpA (BIT:GPI)Today we will run through one way of estimating the intrinsic value of GPI SpA ( BIT:GPI ) by projecting its future...Is New 90 Day High Low • Feb 05New 90-day high: €8.40The company is up 26% from its price of €6.66 on 06 November 2020. The Italian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €9.42 per share.공고 • Jan 24GPI SpA (BIT:GPI) acquired remaining 40% stake in Hemasoft Software S.L for €5.7 million.GPI SpA (BIT:GPI) acquired the remaining 40% stake in Hemasoft Software S.L for €5.7 million on January 22, 2021. GPI SpA (BIT:GPI) completed the acquisition of the remaining 40% stake in Hemasoft Software S.L for on January 22, 2021.공고 • Jan 06GPI SpA (BIT:GPI) completed the acquisition of MEDINFO GROUP.GPI SpA (BIT:GPI) signed an agreement to acquire MEDINFO GROUP for €9 million on May 25, 2020. The purchase price will be paid at closing with a price adjustment mechanism up to €3 million. The acquisition will be financed by means of part of the mini bond issued on December 20, 2019. In 2019, MEDINFO GROUP reported revenue of €3.9 million and an EBITDA of approximately €1.3 million. The transaction is expected to complete by September 30, 2020. GPI SpA (BIT:GPI) completed the acquisition of MEDINFO GROUP on January 4, 2021. The consideration paid is €10.4 million and additional €1.2 million calculated according to the adjustment mechanism agreed between the parties, to be paid according to the results of the years 2020 and 2021.Is New 90 Day High Low • Jan 05New 90-day high: €7.74The company is up 15% from its price of €6.74 on 07 October 2020. The Italian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €8.57 per share.분석 기사 • Dec 28How Much Did GPI's(BIT:GPI) Shareholders Earn From Share Price Movements Over The Last Three Years?While not a mind-blowing move, it is good to see that the GPI SpA ( BIT:GPI ) share price has gained 11% in the last...Is New 90 Day High Low • Dec 10New 90-day high: €7.52The company is up 13% from its price of €6.68 on 10 September 2020. The Italian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €7.01 per share.분석 기사 • Nov 29Taking A Look At GPI SpA's (BIT:GPI) ROEOne of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...Is New 90 Day High Low • Nov 19New 90-day high: €7.10The company is up 7.0% from its price of €6.66 on 21 August 2020. The Italian market is also up 7.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Healthcare Services industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.64 per share.Is New 90 Day High Low • Oct 29New 90-day low: €6.42The company is down 3.0% from its price of €6.64 on 30 July 2020. The Italian market is down 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Healthcare Services industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.46 per share.Reported Earnings • Oct 03First half earnings releasedOver the last 12 months the company has reported total profits of €8.28m, down 4.5% from the prior year. Total revenue was €247.7m over the last 12 months, up 12% from the prior year.공고 • Sep 08GPI SpA announced that it expects to receive €4.5 million in fundingGPI SpA (BIT:GPI) announced a private placement of 3.5% 2019-2025 non-convertible bond notes for gross proceeds of €4.5 million on September 4, 2020. The notes bear a fixed coupon rate of 3.5% per annum and will mature in 2025.공고 • Aug 01GPI SpA (BIT:GPI) acquired the remaining 30% stake in BIM Italia Srl for €5.1 million.GPI SpA (BIT:GPI) acquired the remaining 30% stake in BIM Italia Srl for €5.1 million on July 31, 2020. The transaction was supported with a loan from Sparkasse Cassa di Risparmio di Bolzano. Post completion of the transaction, GPI SpA now owns the entire 100% stake in BIM Italia Srl. GPI SpA (BIT:GPI) completed the acquisition of the remaining 30% stake in BIM Italia Srl on July 31, 2020.공고 • Jul 31GPI SpA (BIT:GPI) completed the acquisition of Intelligence Systems Business Unit from Oslo Srl.GPI SpA (BIT:GPI) signed an agreement to acquire Intelligence Systems Business Unit from Oslo Srl for €5.6 million on January 16, 2020. As per terms, a new company will be set up from Intelligence Systems Business Unit of Oslo Srl in which GPI SpA will acquire 65% stake for €5.6 million plus earn-out. the consideration shall be paid with resources from bond and in kind. The remaining 35% stake shall be acquired through put & call options. GPI SpA (BIT:GPI) completed the acquisition of Intelligence Systems Business Unit from Oslo Srl on April 10, 2020.매출 및 비용 세부 내역GPI가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이BIT:GPI 매출, 비용 및 순이익 (EUR Millions)날짜매출순이익일반관리비연구개발비31 Dec 25546164030 Sep 25539163030 Jun 25531163031 Mar 25521163031 Dec 24510153030 Sep 24497113030 Jun 2448473031 Mar 2445943031 Dec 2343313030 Jun 2336423031 Mar 2335542031 Dec 2234762030 Sep 22352112030 Jun 22344113031 Mar 22335112031 Dec 21327112030 Sep 21316111030 Jun 21306120031 Mar 21288120031 Dec 20271120030 Sep 20259100030 Jun 2024880031 Mar 2024490031 Dec 19241100030 Sep 1923192030 Jun 1922193031 Mar 1921294031 Dec 1820494030 Sep 1819884030 Jun 1819374031 Mar 1818674031 Dec 1718083030 Sep 1716773030 Jun 1715472031 Mar 1714562031 Dec 1613662031 Dec 1589020양질의 수익: GPI는 고품질 수익을 보유하고 있습니다.이익 마진 증가: GPI의 현재 순 이익률 (3%)은 지난해 (2.9%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: GPI의 수익은 지난 5년 동안 연평균 6.1% 증가했습니다.성장 가속화: 지난 1년간 GPI 의 수익 증가율(7.9%)은 연간 평균(6.1%)을 초과합니다.수익 대 산업: GPI의 지난 1년 수익 증가율(7.9%)은 Healthcare Services 업계의 1%를 상회했습니다.자기자본이익률높은 ROE: GPI의 자본 수익률(5%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YHealthcare 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/18 05:52종가2026/08/18 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스GPI S.p.A.는 5명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Andrea TodeschiniBanca Akros S.p.A. (ESN)Gianluca BertuzzoIntermonte SIM S.p.A.Alessandro CugliettaTPICAP Midcap2명의 분석가 더 보기
Reported Earnings • Mar 31Full year 2025 earnings releasedFull year 2025 results: Revenue: €546.2m (up 7.1% from FY 2024). Net income: €16.2m (up 6.4% from FY 2024). Profit margin: 3.0% (in line with FY 2024). Revenue is forecast to grow 5.4% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Healthcare Services industry in Europe.
공고 • Jan 22+ 1 more updateGPI S.p.A. to Report Fiscal Year 2025 Results on Mar 30, 2026GPI S.p.A. announced that they will report fiscal year 2025 results on Mar 30, 2026
공고 • Jul 08GPI S.p.A. to Report First Half, 2025 Results on Sep 29, 2025GPI S.p.A. announced that they will report first half, 2025 results on Sep 29, 2025
Reported Earnings • Mar 30Full year 2024 earnings releasedFull year 2024 results: Revenue: €509.9m (up 18% from FY 2023). Net income: €15.2m (up 485% from FY 2023). Profit margin: 3.0% (up from 0.6% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.2% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.
Reported Earnings • Oct 02First half 2024 earnings releasedFirst half 2024 results: Revenue: €236.4m (up 23% from 1H 2023). Net income: €3.08m (up 439% from 1H 2023). Profit margin: 1.3% (up from 0.3% in 1H 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.
분석 기사 • Apr 14GPI's (BIT:GPI) Problems Go Beyond Weak ProfitGPI S.p.A.'s ( BIT:GPI ) recent weak earnings report didn't cause a big stock movement. However, we believe that...
Upcoming Dividend • Jul 13Upcoming dividend of €0.60 per shareEligible shareholders must have bought the stock before 20 July 2026. Payment date: 22 July 2026. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.1%. Lower than top quartile of Italian dividend payers (4.6%). Higher than average of industry peers (1.7%).
Buy Or Sell Opportunity • Jul 09Now 22% overvaluedOver the last 90 days, the stock has fallen 11% to €14.78. The fair value is estimated to be €12.15, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 56%. For the next 3 years, revenue is forecast to grow by 4.6% per annum. Earnings are also forecast to grow by 22% per annum over the same time period.
Buy Or Sell Opportunity • Jun 15Now 22% overvaluedOver the last 90 days, the stock has fallen 11% to €14.60. The fair value is estimated to be €11.95, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 56%. For the next 3 years, revenue is forecast to grow by 4.6% per annum. Earnings are also forecast to grow by 22% per annum over the same time period.
Buy Or Sell Opportunity • May 27Now 21% overvaluedOver the last 90 days, the stock has fallen 16% to €14.78. The fair value is estimated to be €12.23, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 56%. For the next 3 years, revenue is forecast to grow by 4.6% per annum. Earnings are also forecast to grow by 22% per annum over the same time period.
새로운 내러티브 • Apr 28Ehealth Tenders And AI Adoption Will Shape Margins While Valuation Remains BalancedCatalysts About GPI GPI provides eHealth and automation solutions for healthcare systems, with a focus on software for hospitals, diagnostics, critical care and drug management. What are the underlying business or industry changes driving this perspective?
새로운 내러티브 • Apr 14Digital Health Transformation And AI Adoption Will Reshape This eHealth Provider’s Long Term ProspectsCatalysts About GPI GPI provides eHealth and digital health software, automation and related services to public and private health care customers in Italy and internationally. What are the underlying business or industry changes driving this perspective?
Declared Dividend • Apr 01Dividend increased to €0.60Dividend of €0.60 is 20% higher than last year. Ex-date: 20th July 2026 Payment date: 22nd July 2026 Dividend yield will be 3.6%, which is higher than the industry average of 0.9%. Sustainability & Growth Dividend is not adequately covered by earnings (91% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 5.8% per year over the past 9 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 1.3% to bring the payout ratio under control. However, EPS is expected to remain steady over the next 2 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.
Reported Earnings • Mar 31Full year 2025 earnings releasedFull year 2025 results: Revenue: €546.2m (up 7.1% from FY 2024). Net income: €16.2m (up 6.4% from FY 2024). Profit margin: 3.0% (in line with FY 2024). Revenue is forecast to grow 5.4% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Healthcare Services industry in Europe.
공고 • Mar 31GPI S.p.A. announces Annual dividend, payable on July 22, 2026GPI S.p.A. announced Annual dividend of EUR 0.6000 per share payable on July 22, 2026, ex-date on July 20, 2026 and record date on July 21, 2026.
분석 기사 • Jan 24Why Investors Shouldn't Be Surprised By GPI S.p.A.'s (BIT:GPI) P/EGPI S.p.A.'s ( BIT:GPI ) price-to-earnings (or "P/E") ratio of 31.3x might make it look like a strong sell right now...
공고 • Jan 22+ 1 more updateGPI S.p.A. to Report Fiscal Year 2025 Results on Mar 30, 2026GPI S.p.A. announced that they will report fiscal year 2025 results on Mar 30, 2026
Valuation Update With 7 Day Price Move • Nov 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €14.82, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Healthcare Services industry in Europe. Total returns to shareholders of 28% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.86 per share.
New Risk • Nov 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Dividend is not well covered by earnings and cash flows. Payout ratio: 91% Dividend per share is over 21x cash flows per share. Minor Risk Share price has been volatile over the past 3 months (5.9% average weekly change).
Price Target Changed • Oct 14Price target increased by 11% to €18.57Up from €16.67, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of €17.84. Stock is up 44% over the past year. The company is forecast to post earnings per share of €0.77 for next year compared to €0.53 last year.
New Risk • Aug 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Dividend is not well covered by earnings and cash flows. Payout ratio: 95% Paying a dividend despite having no free cash flows. Minor Risk Share price has been volatile over the past 3 months (5.3% average weekly change).
공고 • Jul 17KKR Reportedly Mulls Acquisition of GPIKKR & Co. Inc. (NYSE:KKR), the buyout firm that’s been scouting for takeover targets amid the recent market volatility, is considering a potential acquisition of Italian health-care technology firm GPI S.p.A. (BIT:GPI), according to people with knowledge of the matter. The US private equity firm has been speaking with advisers in recent weeks as it considers a potential deal to take Trent-based GPI private, the people said, asking not to be identified as the matter is private. The stock is up about 27% in Milan trading this year, giving the company a market value of about €385 million ($446 million). An investment vehicle backed by GPI Chief Executive Officer Fausto Manzana is the company’s biggest shareholder, with a 48% stake that’s equivalent to 57% of the voting rights, according to its annual report. Deliberations are ongoing, though there’s no certainty they will lead to a transaction, the people said. A representative for KKR declined to comment. A spokesperson for GPI didn’t comment.
Upcoming Dividend • Jul 14Upcoming dividend of €0.50 per shareEligible shareholders must have bought the stock before 21 July 2025. Payment date: 23 July 2025. Payout ratio is on the higher end at 95% but the company is not cash flow positive. Trailing yield: 3.8%. Lower than top quartile of Italian dividend payers (5.1%). Higher than average of industry peers (1.1%).
분석 기사 • Jul 10GPI S.p.A. (BIT:GPI) Stock Catapults 25% Though Its Price And Business Still Lag The IndustryDespite an already strong run, GPI S.p.A. ( BIT:GPI ) shares have been powering on, with a gain of 25% in the last...
공고 • Jul 08GPI S.p.A. to Report First Half, 2025 Results on Sep 29, 2025GPI S.p.A. announced that they will report first half, 2025 results on Sep 29, 2025
분석 기사 • Jul 05Why GPI S.p.A. (BIT:GPI) Could Be Worth WatchingGPI S.p.A. ( BIT:GPI ), might not be a large cap stock, but it saw a significant share price rise of 59% in the past...
공고 • Jul 02GPI S.p.A. (BIT:GPI) acquired remaining 35% stake in Tesi Elettronica E Sistemi Informativi S.P.A. for €27.8 million.GPI S.p.A. (BIT:GPI) acquired remaining 35% stake in Tesi Elettronica E Sistemi Informativi S.P.A. for €27.8 million on June 30, 2025. The price for acquiring the remaining shares, which represent 35% of TESI's share capital, is €27.8 million i.e, Payment for the acquisition of a 35% stake in TESI was made using the following methods: (i) a €5 million deposit upon signing, of which €4 million in cash and €1 million via the transfer of Gpi; (ii) the amount of €15.9 million in cash paid at the closing, which took place today, 30 June 2025; (iii) the difference settled through the assumption and offsetting of the sellers’ payables to companies within the Tesi group. GPI S.p.A. (BIT:GPI) completed the acquisition of remaining 35% stake in Tesi Elettronica E Sistemi Informativi S.P.A. on June 30, 2025.
Major Estimate Revision • Apr 16Consensus EPS estimates fall by 20%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from €0.98 to €0.783 per share. Revenue forecast steady at €534.8m. Net income forecast to grow 49% next year vs 42% growth forecast for Healthcare Services industry in Italy. Consensus price target of €16.67 unchanged from last update. Share price rose 7.7% to €8.66 over the past week.
Major Estimate Revision • Apr 04Consensus EPS estimates increase by 31%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from €0.748 to €0.98. Revenue forecast steady at €530.9m. Net income forecast to grow 82% next year vs 36% growth forecast for Healthcare Services industry in Italy. Consensus price target of €16.67 unchanged from last update. Share price fell 8.8% to €8.30 over the past week.
공고 • Apr 02GPI S.p.A. announces Annual dividend, payable on July 23, 2025GPI S.p.A. announced Annual dividend of EUR 0.5000 per share payable on July 23, 2025, ex-date on July 21, 2025 and record date on July 22, 2025.
Reported Earnings • Mar 30Full year 2024 earnings releasedFull year 2024 results: Revenue: €509.9m (up 18% from FY 2023). Net income: €15.2m (up 485% from FY 2023). Profit margin: 3.0% (up from 0.6% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.2% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.
공고 • Mar 20GPI S.p.A., Annual General Meeting, Apr 29, 2025GPI S.p.A., Annual General Meeting, Apr 29, 2025, at 11:00 W. Europe Standard Time.
Buy Or Sell Opportunity • Jan 14Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 18% to €10.16. The fair value is estimated to be €12.76, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has declined by 54%. Revenue is forecast to grow by 12% in 2 years. Earnings are forecast to grow by 143% in the next 2 years.
Buy Or Sell Opportunity • Dec 27Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 20% to €10.08. The fair value is estimated to be €12.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has declined by 54%. Revenue is forecast to grow by 12% in 2 years. Earnings are forecast to grow by 143% in the next 2 years.
Upcoming Dividend • Dec 02Upcoming dividend of €0.35 per shareEligible shareholders must have bought the stock before 09 December 2024. Payment date: 11 December 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.5%. Lower than top quartile of Italian dividend payers (5.6%). Higher than average of industry peers (2.6%).
Buy Or Sell Opportunity • Oct 03Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 1.8% to €12.74. The fair value is estimated to be €10.60, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 10% in 2 years. Earnings are forecast to grow by 187% in the next 2 years.
Reported Earnings • Oct 02First half 2024 earnings releasedFirst half 2024 results: Revenue: €236.4m (up 23% from 1H 2023). Net income: €3.08m (up 439% from 1H 2023). Profit margin: 1.3% (up from 0.3% in 1H 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.
Buy Or Sell Opportunity • Sep 09Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 1.2% to €12.28. The fair value is estimated to be €9.94, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has declined by 46%. For the next 3 years, revenue is forecast to grow by 7.3% per annum. Earnings are also forecast to grow by 47% per annum over the same time period.
Buy Or Sell Opportunity • Aug 08Now 20% overvaluedOver the last 90 days, the stock has fallen 5.8% to €11.98. The fair value is estimated to be €9.94, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has declined by 46%. For the next 3 years, revenue is forecast to grow by 7.3% per annum. Earnings are also forecast to grow by 47% per annum over the same time period.
Upcoming Dividend • May 20Upcoming dividend of €0.50 per shareEligible shareholders must have bought the stock before 27 May 2024. Payment date: 29 May 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 3.8%. Lower than top quartile of Italian dividend payers (5.3%). Higher than average of industry peers (1.6%).
Price Target Changed • Apr 17Price target increased by 7.2% to €16.30Up from €15.20, the current price target is an average from 3 analysts. New target price is 30% above last closing price of €12.50. Stock is up 0.2% over the past year. The company is forecast to post earnings per share of €0.58 for next year compared to €0.09 last year.
분석 기사 • Apr 14GPI's (BIT:GPI) Problems Go Beyond Weak ProfitGPI S.p.A.'s ( BIT:GPI ) recent weak earnings report didn't cause a big stock movement. However, we believe that...
Major Estimate Revision • Apr 04Consensus EPS estimates fall by 41%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from €483.8m to €500.8m. EPS estimate fell from €0.973 to €0.57 per share. Net income forecast to grow 516% next year vs 47% growth forecast for Healthcare Services industry in Italy. Consensus price target up from €15.20 to €15.53. Share price was steady at €11.92 over the past week.
Reported Earnings • Mar 31Full year 2023 earnings releasedFull year 2023 results: Revenue: €433.4m (up 20% from FY 2022). Net income: €2.60m (down 74% from FY 2022). Profit margin: 0.6% (down from 2.8% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.1% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.
공고 • Mar 21Zucchetti Hospitality S.R.L. completed the acquisition of Argentea S.r.l. from GPI S.p.A. (BIT:GPI).Zucchetti Hospitality S.R.L. signed an agreement to acquire Argentea S.r.l. from GPI S.p.A. (BIT:GPI) for approximately €105 million on March 15, 2024. The consideration for the sale of 100% of Argentea S.r.l., to be paid in full in cash at closing, has been agreed upon at approximately €99 million, based on an equity value of Argentea S.r.l. of approximately €105 million. An earn-out clause is also provided for, whereby the buyer undertakes to pay Gpi S.p.A. an additional amount of €6 million, on the sole condition that Argentea S.r.l.'s FY 2024 EBITDA, to be calculated in continuity with previous management criteria, is at least equal to that of FY 2023. In FY 2023, Argentea S.r.l. reported production value of €16.3 million and EBITDA of €6.9 million. This transaction is expected to be completed by end of March 2024. Intermonte acted as financial advisor to Zucchetti Hospitality S.R.L. Equita acted as financial advisor, EY-Parthenon as industrial advisor and Studio Legale Pavia e Ansaldo acted as legal advisor to GPI S.p.A. (BIT:GPI). Zucchetti Hospitality S.R.L. completed the acquisition of Argentea S.r.l. from GPI S.p.A. (BIT:GPI) on March 20, 2024.
분석 기사 • Feb 27Why Investors Shouldn't Be Surprised By GPI S.p.A.'s (BIT:GPI) 26% Share Price SurgeGPI S.p.A. ( BIT:GPI ) shares have continued their recent momentum with a 26% gain in the last month alone. Not all...
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €10.86, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Healthcare Services industry in Europe. Total returns to shareholders of 30% over the past three years.
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €10.86, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Healthcare Services industry in Europe. Total returns to shareholders of 30% over the past three years.
분석 기사 • Dec 30GPI S.p.A.'s (BIT:GPI) P/E Is Still On The Mark Following 25% Share Price BounceGPI S.p.A. ( BIT:GPI ) shareholders would be excited to see that the share price has had a great month, posting a 25...
분석 기사 • Dec 15These 4 Measures Indicate That GPI (BIT:GPI) Is Using Debt ExtensivelyDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
분석 기사 • Oct 27GPI (BIT:GPI) Is Reinvesting At Lower Rates Of ReturnWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
Price Target Changed • Oct 20Price target decreased by 9.3% to €15.20Down from €16.77, the current price target is an average from 3 analysts. New target price is 87% above last closing price of €8.14. Stock is down 31% over the past year. The company is forecast to post earnings per share of €0.78 for next year compared to €0.35 last year.
Major Estimate Revision • Oct 01Consensus EPS estimates increase by 25%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has improved. 2023 revenue forecast increased from €418.4m to €426.1m. EPS estimate increased from €0.635 to €0.791 per share. Net income forecast to grow 81% next year vs 28% growth forecast for Healthcare Services industry in Italy. Consensus price target of €16.83 unchanged from last update. Share price fell 3.6% to €8.95 over the past week.
Upcoming Dividend • May 08Upcoming dividend of €0.50 per share at 4.2% yieldEligible shareholders must have bought the stock before 15 May 2023. Payment date: 17 May 2023. Payout ratio is on the higher end at 85% but the company is not cash flow positive. Trailing yield: 4.2%. Lower than top quartile of Italian dividend payers (5.2%). Higher than average of industry peers (1.3%).
Major Estimate Revision • Apr 18Consensus EPS estimates fall by 15%The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from €0.59 to €0.50. Revenue forecast unchanged from €420.5m at last update. Net income forecast to grow 47% next year vs 30% growth forecast for Healthcare Services industry in Italy. Consensus price target of €17.43 unchanged from last update. Share price fell 2.3% to €12.50 over the past week.
Major Estimate Revision • Mar 31Consensus EPS estimates fall by 40%, revenue upgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from €409.2m to €420.5m. EPS estimate fell from €0.981 to €0.59 per share. Net income forecast to grow 36% next year vs 30% growth forecast for Healthcare Services industry in Italy. Consensus price target broadly unchanged at €17.43. Share price fell 2.7% to €12.80 over the past week.
Major Estimate Revision • Feb 19Consensus EPS estimates fall by 16%The consensus outlook for fiscal year 2022 has been updated. 2022 EPS estimate fell from €0.668 to €0.558 per share. Revenue forecast steady at €355.7m. Net income forecast to grow 37% next year vs 29% growth forecast for Healthcare Services industry in Italy. Consensus price target down from €18.03 to €17.63. Share price fell 3.8% to €13.76 over the past week.
Major Estimate Revision • Dec 26Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from €0.85 to €0.65 per share. Revenue forecast steady at €354.8m. Net income forecast to grow 46% next year vs 39% growth forecast for Healthcare Services industry in Italy. Consensus price target broadly unchanged at €18.03. Share price was steady at €13.64 over the past week.
Major Estimate Revision • Dec 08Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from €1.01 to €0.85 per share. Revenue forecast steady at €354.0m. Net income forecast to grow 47% next year vs 39% growth forecast for Healthcare Services industry in Italy. Consensus price target of €17.97 unchanged from last update. Share price was steady at €13.36 over the past week.
공고 • Nov 23GPI S.p.A. acquired 65% stake in Tesi Elettronica E Sistemi Informativi S.P.A. from Tesi Group, Sorean S.r.l., Aef Luxor Group SL and Magica S.R.L. for Tesi Elettronica E Sistemi Informativi S.P.A. for €58.5 million.GPI (GPI:IM) signed the letter of intent to acquire 75% stake in Tesi Elettronica E Sistemi Informativi S.P.A. from Tesi Group, Sorean S.r.l., Aef Luxor Group SL and Magica S.R.L. on January 4, 2022. On May 23, 2022, GPI S.p.A. signed an agreement to acquire a 65% stake in Tesi Elettronica E Sistemi Informativi S.P.A. from Tesi Group, Sorean S.r.l., Aef Luxor Group SL and Magica S.R.L. for Tesi Elettronica E Sistemi Informativi S.P.A. for €58.5 million. The consideration will be settled in the following ways: a deposit of €8 million at signing; €28.3 million to be paid at the closing, the remaining portion, equal to €22.2 million, by January 31, 2023. Completion of the transaction is subject to the approval of the competent bodies, as well as to any authorizations necessary from the antitrust authorities. The transaction is expected to complete by September 30, 2022. On May 23, 2022, GPI S.p.A. agreed with the selling parties to extend the closing date to November, 29 2022. GPI S.p.A. completed the acquisition of 65% stake in Tesi Elettronica E Sistemi Informativi S.P.A. from Tesi Group, Sorean S.r.l., Aef Luxor Group SL and Magica S.R.L. for Tesi Elettronica E Sistemi Informativi S.P.A. for €58.5 million on November 21, 2022. The consideration of €28.3 million paid at the closing was funded using a combination of available liquidity and short-term bank loans. Studio Baldi & Partners acted as legal advisor, Intermonte SIM S.p.A. acted as financial advisor to GPI S.p.A.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Independent Director Michele Andreaus was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
분석 기사 • Nov 02Is There Now An Opportunity In GPI S.p.A. (BIT:GPI)?GPI S.p.A. ( BIT:GPI ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the...
Reported Earnings • Sep 18First half 2022 earnings releasedFirst half 2022 results: Revenue: €168.9m (up 11% from 1H 2021). Net income: €331.0k (up €359.0k from 1H 2021). Profit margin: 0.2% (up from 0% in 1H 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10.0% growth forecast for the Healthcare Services industry in Europe.
Price Target Changed • Aug 17Price target decreased to €16.10Down from €18.50, the current price target is an average from 2 analysts. New target price is 15% above last closing price of €14.02. Stock is up 12% over the past year. The company is forecast to post earnings per share of €0.90 for next year compared to €0.61 last year.
분석 기사 • Jun 18What Does GPI S.p.A.'s (BIT:GPI) Share Price Indicate?GPI S.p.A. ( BIT:GPI ), might not be a large cap stock, but it saw significant share price movement during recent...
Upcoming Dividend • May 09Upcoming dividend of €0.50 per shareEligible shareholders must have bought the stock before 16 May 2022. Payment date: 18 May 2022. Payout ratio is on the higher end at 82% but the company is not cash flow positive. Trailing yield: 3.8%. Lower than top quartile of Italian dividend payers (4.8%). Higher than average of industry peers (1.4%).
Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 7 experienced directors. 4 highly experienced directors. 4 independent directors (6 non-independent directors). Independent Director Michele Andreaus was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Buying Opportunity • Mar 31Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be €17.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 14%. Revenue is forecast to grow by 14% in 2 years. Earnings is forecast to grow by 42% in the next 2 years.
Price Target Changed • Jan 06Price target increased to €18.50Up from €17.07, the current price target is an average from 3 analysts. New target price is 10% above last closing price of €16.75. Stock is up 113% over the past year. The company is forecast to post earnings per share of €0.79 for next year compared to €0.75 last year.
공고 • Jan 06GPI (GPI:IM) signed the letter of intent to acquire 75% stake in Tesi Elettronica E Sistemi Informativi S.P.A. from Tesi Group, Sorean S.r.l., Aef Luxor Group SL and Magica S.R.L.GPI (GPI:IM) signed the letter of intent to acquire 75% stake in Tesi Elettronica E Sistemi Informativi S.P.A. from Tesi Group, Sorean S.r.l., Aef Luxor Group SL and Magica S.R.L. on January 4, 2022.The letter of intent, guaranteed by an exclusivity clause until 28 February 2022, provides for the signing of the binding agreement by 28 February 2022 and for the closing, indicatively by 30 April 2022, subject to the positive and satisfactory outcome of the due diligence carried out by GPI. Completion of the transaction is subject to the approval of the competent bodies, as well as to any authorizations necessary from the antitrust authorities.
분석 기사 • Dec 27Here's What To Make Of GPI's (BIT:GPI) Decelerating Rates Of ReturnFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
분석 기사 • Nov 30Here's Why GPI (BIT:GPI) Has A Meaningful Debt BurdenSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Price Target Changed • Nov 27Price target increased to €18.17Up from €16.73, the current price target is an average from 3 analysts. New target price is 42% above last closing price of €12.80. Stock is up 79% over the past year. The company is forecast to post earnings per share of €0.83 for next year compared to €0.75 last year.
분석 기사 • Oct 06GPI's (BIT:GPI) Promising Earnings May Rest On Soft FoundationsDespite posting some strong earnings, the market for GPI S.p.A.'s ( BIT:GPI ) stock hasn't moved much. Our analysis...
Price Target Changed • Jul 27Price target increased to €16.23Up from €14.63, the current price target is an average from 3 analysts. New target price is 21% above last closing price of €13.45. Stock is up 94% over the past year.
Upcoming Dividend • Jul 19Upcoming dividend of €0.50 per shareEligible shareholders must have bought the stock before 26 July 2021. Payment date: 28 July 2021. Trailing yield: 3.6%. Lower than top quartile of Italian dividend payers (3.8%). Higher than average of industry peers (1.0%).
분석 기사 • Jun 05An Intrinsic Calculation For GPI SpA (BIT:GPI) Suggests It's 33% UndervaluedToday we'll do a simple run through of a valuation method used to estimate the attractiveness of GPI SpA ( BIT:GPI ) as...
분석 기사 • Apr 30GPI (BIT:GPI) Has A Somewhat Strained Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Apr 13Is GPI SpA's (BIT:GPI) 5.0% Dividend Sustainable?Could GPI SpA ( BIT:GPI ) be an attractive dividend share to own for the long haul? Investors are often drawn to strong...
분석 기사 • Mar 29GPI (BIT:GPI) Might Be Having Difficulty Using Its Capital EffectivelyFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
분석 기사 • Mar 07Is GPI SpA's (BIT:GPI) 12% ROE Strong Compared To Its Industry?One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Major Estimate Revision • Feb 12Analysts increase EPS estimates to €0.64The 2020 consensus revenue estimate increased from €256.6m to €264.4m. The earnings per share estimate also received an upgrade from €0.52 to €0.64 for the same period. Net income is expected to shrink by 2.7% next year compared to 29% growth forecast for the Healthcare Services industry in Italy . The consensus price target increased from €10.50 to €10.85. Share price is up 8.1% to €9.08 over the past week.
분석 기사 • Feb 08Estimating The Intrinsic Value Of GPI SpA (BIT:GPI)Today we will run through one way of estimating the intrinsic value of GPI SpA ( BIT:GPI ) by projecting its future...
Is New 90 Day High Low • Feb 05New 90-day high: €8.40The company is up 26% from its price of €6.66 on 06 November 2020. The Italian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €9.42 per share.
공고 • Jan 24GPI SpA (BIT:GPI) acquired remaining 40% stake in Hemasoft Software S.L for €5.7 million.GPI SpA (BIT:GPI) acquired the remaining 40% stake in Hemasoft Software S.L for €5.7 million on January 22, 2021. GPI SpA (BIT:GPI) completed the acquisition of the remaining 40% stake in Hemasoft Software S.L for on January 22, 2021.
공고 • Jan 06GPI SpA (BIT:GPI) completed the acquisition of MEDINFO GROUP.GPI SpA (BIT:GPI) signed an agreement to acquire MEDINFO GROUP for €9 million on May 25, 2020. The purchase price will be paid at closing with a price adjustment mechanism up to €3 million. The acquisition will be financed by means of part of the mini bond issued on December 20, 2019. In 2019, MEDINFO GROUP reported revenue of €3.9 million and an EBITDA of approximately €1.3 million. The transaction is expected to complete by September 30, 2020. GPI SpA (BIT:GPI) completed the acquisition of MEDINFO GROUP on January 4, 2021. The consideration paid is €10.4 million and additional €1.2 million calculated according to the adjustment mechanism agreed between the parties, to be paid according to the results of the years 2020 and 2021.
Is New 90 Day High Low • Jan 05New 90-day high: €7.74The company is up 15% from its price of €6.74 on 07 October 2020. The Italian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €8.57 per share.
분석 기사 • Dec 28How Much Did GPI's(BIT:GPI) Shareholders Earn From Share Price Movements Over The Last Three Years?While not a mind-blowing move, it is good to see that the GPI SpA ( BIT:GPI ) share price has gained 11% in the last...
Is New 90 Day High Low • Dec 10New 90-day high: €7.52The company is up 13% from its price of €6.68 on 10 September 2020. The Italian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €7.01 per share.
분석 기사 • Nov 29Taking A Look At GPI SpA's (BIT:GPI) ROEOne of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Is New 90 Day High Low • Nov 19New 90-day high: €7.10The company is up 7.0% from its price of €6.66 on 21 August 2020. The Italian market is also up 7.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Healthcare Services industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.64 per share.
Is New 90 Day High Low • Oct 29New 90-day low: €6.42The company is down 3.0% from its price of €6.64 on 30 July 2020. The Italian market is down 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Healthcare Services industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.46 per share.
Reported Earnings • Oct 03First half earnings releasedOver the last 12 months the company has reported total profits of €8.28m, down 4.5% from the prior year. Total revenue was €247.7m over the last 12 months, up 12% from the prior year.
공고 • Sep 08GPI SpA announced that it expects to receive €4.5 million in fundingGPI SpA (BIT:GPI) announced a private placement of 3.5% 2019-2025 non-convertible bond notes for gross proceeds of €4.5 million on September 4, 2020. The notes bear a fixed coupon rate of 3.5% per annum and will mature in 2025.
공고 • Aug 01GPI SpA (BIT:GPI) acquired the remaining 30% stake in BIM Italia Srl for €5.1 million.GPI SpA (BIT:GPI) acquired the remaining 30% stake in BIM Italia Srl for €5.1 million on July 31, 2020. The transaction was supported with a loan from Sparkasse Cassa di Risparmio di Bolzano. Post completion of the transaction, GPI SpA now owns the entire 100% stake in BIM Italia Srl. GPI SpA (BIT:GPI) completed the acquisition of the remaining 30% stake in BIM Italia Srl on July 31, 2020.
공고 • Jul 31GPI SpA (BIT:GPI) completed the acquisition of Intelligence Systems Business Unit from Oslo Srl.GPI SpA (BIT:GPI) signed an agreement to acquire Intelligence Systems Business Unit from Oslo Srl for €5.6 million on January 16, 2020. As per terms, a new company will be set up from Intelligence Systems Business Unit of Oslo Srl in which GPI SpA will acquire 65% stake for €5.6 million plus earn-out. the consideration shall be paid with resources from bond and in kind. The remaining 35% stake shall be acquired through put & call options. GPI SpA (BIT:GPI) completed the acquisition of Intelligence Systems Business Unit from Oslo Srl on April 10, 2020.
